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8 Objectives. The rate of antidepressant use in the United Kingdom has outpaced diagnostic increases in the prevalence of
9 depression. Research has suggested that personal and socioeconomic risk factors may be contributing to antidepressant
10 use. To date, few studies have addressed these possible contributions. Thus, this study aimed to assess the relative
11 strength of personal, socioeconomic and trauma-related risk factors in predicting antidepressant use.
12 Methods. Data were derived from the Adult Psychiatric Morbidity Survey (n= 7403), a nationally representative
13 household sample of adults residing in England in 2007. Amultivariate binary logistic regressionmodel was developed to
14 assess the associations between personal, socioeconomic and trauma-related risk factors and current antidepressant use.
15 Results. The strongest predictor of current antidepressant use was meeting the criteria for an ICD-10 depressive episode
16 [odds ratio (OR)= 9.04]. Other signiﬁcant predictors of antidepressant use in this analysis included English as ﬁrst
17 language (OR= 3.45), female gender (OR= 1.98), unemployment (OR= 1.82) and childhood sexual abuse (OR= 1.53).
18 Conclusions. Several personal, socioeconomic and trauma-related factors signiﬁcantly contributed to antidepressant use
19 in the multivariate model speciﬁed. These ﬁndings aid our understanding of the broader context of antidepressant use in
20 the United Kingdom.
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23 Rates of antidepressant use in the United Kingdom are
24 amongst the highest in Europe (McClure, 2014) and are
25 continually increasing; recent health statistics pub-
26 lished by the Organisation for Economic Co-operation
27 and Development (OECD, 2017) indicate that in 2015,
28 the estimated daily dosage of antidepressants was
29 94.2/1000 people in the United Kingdom, approxi-
30 mately double the estimated daily dosage in 2005 (47.3/
31 1000). Whilst antidepressant use has increased, the pre-
32 valence of depression has not increased signiﬁcantly
33 (Baxter et al. 2014). According to estimates from the most
34 recent edition of the Adult Psychiatric Morbidity Survey
35 (APMS) the prevalence of depression in England has
36 increased by 1% between 2007 and 2014 (McManus et al.
37 2016). In addition, epidemiological evidence suggests
38 that any increases observed in prevalence rates of
39 depression can be explained by population growth and
40 changing age structures (Baxter et al. 2014). The reasons
41behind this disparity between the prevalence of depres-
42sion and rates of antidepressant use remain unclear
43(Munoz-Arroyo et al. 2006). Depression irrefutably
44remains a strong predictor of antidepressant use; results
45from the European Study of the Epidemiology of Mental
46Disorders indicated that a diagnosis of depression
47increases the probability of antidepressant use ﬁvefold
48(Demyttenaere et al. 2008). However, the disparity
49between antidepressant prescribing rates and rates of
50depression suggests that depression is only one of many
51potential risk factors for antidepressant use (Demytte-
52naere et al. 2008). Research has now focused on a range of
53personal, physical health, socioeconomic and trauma-
54related factors in predicting antidepressant use
55(Demyttenaere et al. 2008; Butterworth et al. 2013; Lewer
56et al. 2015).
57The small numbers of studies that have addressed
58antidepressant use in the general population have
59reported that age and gender are strong predictors
60(Demyttenaere et al. 2008; Lewer et al. 2015); the risk for
61antidepressant use generally increases from young
62adulthood to middle adulthood [odds ratio (OR)=
631.69], and declines in older adulthood (OR= 1.45)
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64 (Lewer et al. 2015). In addition, epidemiological
65 evidence has shown that being female is associated
66 with an approximate 80% increase in risk for anti-
67 depressant use (Benson et al. 2015). This is expected
68 given that patterns of antidepressant use tend to follow
69 those for diagnosis of major depressive disorder
70 (MDD), and epidemiological research has reported that
71 middle age and female gender are signiﬁcant risk
72 factors for MDD (Kessler et al. 2003; Hasin et al. 2005;
73 Seedat et al. 2009). Social isolation has also been linked
74 with antidepressant use. Previous research has shown
75 that loneliness increases the risk of using any psycho-
76 tropic medication (including antidepressants) in older
77 adults by about 50% (Boehlen et al. 2015). Moreover,
78 there is evidence that increases in rates of anti-
79 depressant use may be a consequence of living alone. In
80 an analysis of theHealth 2000 study it was reported that
81 those of working age who lived alone had an 80%
82 higher risk of antidepressant use during the 7-year
83 follow-up period (Pulkki-Råback et al. 2012). There is
84 relatively little research on antidepressant use by
85 migrants. A possible explanation is that only a small
86 proportion (32%) of new migrants to the UK register
87 with a GP (Stagg et al. 2012). Moreover, the Ofﬁce for
88 National Statistics has reported that the top-10 coun-
89 tries of birth for non-UK migrants in 2015 included
90 countries such as India, Pakistan and China (Ofﬁce for
91 National Statistics, 2016). Previous analyses of the
92 perceptions of mental illness in India for example, have
93 shown that depression is less often perceived as a
94 mental disorder than other more serious disorders such
95 as the psychoses (Wig et al. 1980). As such, the medical
96 approach to treatment is less popular than social or
97 more traditional healing methods (Wig et al. 1980).
98 Thus, it appears that migrants may be less likely to use
99 antidepressants as they are (1) less likely to register
100 with a GP, and consequently are (2) less likely to be
101 diagnosed with depression and (3) may have cultural
102 beliefs about mental health and it’s care that is incon-
103 sistent with antidepressant use (Wig et al. 1980;
104 Furnham & Malik, 1994; Stagg et al. 2012).
105 Prescriptions for antidepressants are increasingly
106 common for people managing chronic physical
107 health conditions, such as ﬁbromyalgia and diabetes
108 (Mojtabai & Olfson, 2011; Mercier et al. 2013). Whilst
109 there is evidence that the prevalence of antidepressant
110 use is higher in those who have chronic physical con-
111 ditions, there is little signiﬁcant evidence for chronic
112 physical conditions as predictors of antidepressant use
113 (Demyttenaere et al. 2008). This may be due in part to
114 there being little in the way of a theoretical framework
115 for understanding the association between physical
116 health and antidepressant use. If we look to the
117 relationship between depression and physical health
118 for more information, research points to the role of the
119functional impairment (Zeiss et al. 1996). According to
120the Integrative Model of Depression, poor physical health
121(without functional impairment) is not a signiﬁcant
122predictor of depression (Lewinsohn et al. 1985).
123This suggests that evaluating physical health-related
124functional impairment (PHFI) as a predictor of anti-
125depressant use, rather than the presence of any one
126chronic physical condition, would be prudent.
127Socioeconomic disadvantage has long been recog-
128nized as a risk factor for depression (Lorant et al. 2003),
129and more recently recognized as a risk factor for anti-
130depressant use (Butterworth et al. 2013). Butterworth
131et al. (2013) reported that unemployment signiﬁcantly
132increased risk of antidepressant use by more than
1332.5 times (OR= 2.67) and those who had experienced
134ﬁnancial hardship in the previous year were almost
135three times as likely (OR= 2.87) to be using anti-
136depressants than those who had not. Indeed, all social
137disadvantage factors were reported to increase the
138likelihood of antidepressant use, although two factors
139(rental housing tenure and not ﬁnishing high school)
140failed to reach statistical signiﬁcance (Butterworth et al.
1412013). These ﬁndings suggest that socioeconomic
142disadvantage is a robust predictor of antidepressant
143use, however, further evidence is required to assess the
144unique contributions of socioeconomic disadvantage
145factors to antidepressant use in a multivariate context,
146as only ﬁnancial hardship remained an independent
147predictor of antidepressant use when depression was
148controlled for (OR= 1.43).
149There is limited research regarding the role of trauma
150exposure in antidepressant use. A small number of
151studies have reported signiﬁcant associations between
152antidepressant use and stressful life events (SLE) such
153as bereavement (Maguire et al. 2017) and divorce
154(Monden et al. 2015). However, there is little research
155addressing cumulative lifetime stress. There is also a
156dearth of research regarding the predictive power of
157traumatic experiences and antidepressant use. Never-
158theless, the literature regarding these risk factors and
159depression provides an indication of the nature of these
160associations. Depression has been consistently asso-
161ciated with victimizing experiences such as domestic
162abuse (Campbell et al. 1995) and homelessness
163(DeForge et al. 2008). It is pertinent to address these
164relationships between trauma factors and anti-
165depressant use further; previous research addressing
166the high levels of antidepressant use amongst those
167reporting traumatic experiences, for example, child-
168hood sexual abuse (CSA), has shown that it can be
169problematic (Anda et al. 2007; Williams et al. 2016).
170According to Anda et al. (2007) those who had scored
171highly on a measure of childhood adversity were three
172times more likely to have been using antidepressants
173than those who reported no negative childhood
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174 experiences. However, adverse childhood experiences
175 are associated with decreases in antidepressant
176 response and remission, in addition to high rates of
177 adverse effects (Williams et al. 2016).
178 The aim of this study was to assess the relative
179 strength of a range of personal, socioeconomic and
180 trauma-related factors in predicting antidepressant use
181 in the UK population. Evidence has indicated that these
182 factors vary in their strength of association. In order
183 of effect size, previous research has shown that a
184 diagnosis of depression (OR= 5.00: Demyttenaere et al.
185 2008), ﬁnancial hardship (OR= 2.87: Butterworth
186 et al. 2013), unemployment (OR= 2.67: Butterworth
187 et al. 2013) and female gender (OR= 1.80: Benson et al.
188 2015) all signiﬁcantly predict antidepressant use. It has
189 also been demonstrated that age is a signiﬁcant but
190 non-linear predictor of antidepressant use, with its
191 strength peaking in middle adulthood (OR= 1.69) and
192 decreasing into older adulthood (OR= 1.45: Lewer et al.
193 2015). Two indicators of socioeconomic disadvantage
194 (rental housing tenure and low/no educational quali-
195 ﬁcations) have shown increased risk for antidepressant
196 use, but these have not reached signiﬁcance (Butter-
197 worth et al. 2013). These factors have nevertheless been
198 included in the investigation as it is difﬁcult to separate
199 the unique effects of highly correlated risk factors such
200 as these. The relative strength of other factors (social
201 isolation, migrant status, PHFI, SLE, victimization and
202 CSA) in predicting antidepressant use in the population
203 is currently unknown. It was hypothesized that each
204 personal (depression, age, gender, social isolation,
205 migrant status and PHFI), socioeconomic disadvantage
206 (employment, housing tenure, educational qualiﬁca-
207 tions and ﬁnancial hardship) and trauma-related (SLE,
208 victimization and CSA) risk factor would be indepen-
209 dently associated with antidepressant use. It was also
210 pertinent to examine these associations in a multivariate
211 context to ascertain the individual contributions of each
212 predictor to antidepressant use when other factors
213 were considered. It was expected that each predictor
214 would signiﬁcantly contribute to the multivariate model
215 developed for predicting antidepressant use.
216 Methods
217 Participants and study measures
218 The data utilized in the current study were derived
219 from the APMS conducted in 2007, a representative
220 sample of the population living in private households
221 in England (McManus et al. 2009). Using the small-users
222 postcode address ﬁle, the National Centre for Social
223 Research adopted a multi-stage stratiﬁed probability-
224 sampling design. The survey consisted of a phase 1 and
225 a phase 2 (clinical) interview. For phase 1 of the survey
22613 214 potentially eligible private households were
227identiﬁed. One adult aged 16 years or over from each
228household was selected for interview using the Kish
229grid method (Kish, 1965). To ensure that the results
230were nationally representative, the data were weighted
231to account for non-response, gender, age and region.
232Comprehensive details of the survey methods can be
233found in the APMS report appendices (McManus et al.
2342009). In total, 57% of those eligible agreed to be
235interviewed for the APMS, resulting in 7403 successful
236interviews (3197 males and 4206 females). The sample
237had a mean age of 51.12 years (S.D.= 18.59). The
238measures utilized in this analysis were based on
239questions asked in the APMS 2007 phase 1 questionnaire.
240Depression
241A single categorical variable was generated to reﬂect
242the severity of depressive symptoms. First, respondents
243were presented with two screening questions asking
244whether they had been ‘feeling sad, miserable or
245depressed’ (1=yes/0=no) or ‘(unable) to enjoy or take
246an interest in things’ (1= yes/0=no) in the past month.
247These questions were common to both the ﬁfth edition
248of the Diagnostic and Statistical Manual of Mental
249Disorders (DSM-5; American Psychiatric Association,
2502013) and the tenth edition of the International Classi-
251ﬁcation of Diseases (ICD-10; World Health Organisa-
252tion, 1993). Second, the APMS used the Clinical
253Interview Schedule Revised (CIS-R; Lewis & Pelosi,
2541990), a structured clinical interview, to generate a
255diagnosis of an ICD-10 2-week depressive episode
256(1= yes/0=no). The resulting variable grouped
257respondents as: ‘no’ to both screening instruments, and
258‘no’ to diagnosis of a depressive episode (0), ‘yes’ to
259one of the two screening instruments (1), ‘yes’ to both
260(2) or met the criteria for diagnosis of a depressive epi-
261sode (3), which superseded responding ‘yes’ to either/
262both screening instrument(s). Previous analysis of the
263concurrence of the CIS-R with other diagnostic tools
264has indicated that in relation to the Schedules for Clin-
265ical Assessment in Neuropsychiatry (SCAN), the CIS-R
266has low sensitivity and high speciﬁcity for ICD-10
267depressive disorders (Jordanova et al. 2004). Thus, the
268development of a combined sub-clinical and clinical
269variable was necessary to increase the range of
270depression severity measured.
271Demographics
272Participants were asked about age, gender, social
273isolation and migrant status. Age was grouped into four
274age bands: 16–29 years; 30–44; 45–59 and 60 or more
275years. Gender was classiﬁed as either male/female (0/1).
276Household size was represented as living alone
277(1=yes/0=no) and used as an indicator of social
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278 isolation. First language was summarized as English/not
279 English (1/0) and used as a proxy for migrant status.
280 Physical health-related functional impairment (PHFI)
281 This was measured using two items from the Short
282 Form-12 (Ware et al. 1996). Respondents were asked
283 whether, in the past 4 weeks, they had (a) accomplished
284 less work or daily activities due to physical health
285 problems, andwhether (b) theywere limited in the type
286 of work or daily activities they could do due to physical
287 health problems. Responses were coded as yes (1) or no
288 (0) and summarized as a single physical health indi-
289 cator (0=no limitation, 1= one limitation noted and
290 2=both limitations noted).
291 Socioeconomic disadvantage
292 Employment, housing tenure, educational qualiﬁca-
293 tions and ﬁnancial hardship (debt and borrowing) were
294 used as indicators of individual-level socioeconomic
295 disadvantage. Respondents were asked whether they
296 were or were not in paid employment during the week
297 preceding the interview. A dichotomous variable based
298 on this question was then derived which classiﬁed
299 respondents as unemployed (1) or employed (0).
300 Tenure was summarized as those in owner-occupation
301 (0) and those who in rented accommodation (1).
302 Education was assessed in the survey as qualiﬁcations
303 attained ranging from none to degree level and above,
304 and was summarized as no qualiﬁcations attained
305 (1) or some qualiﬁcations attained (0). Next, two
306 variables – debt and borrowing – described respon-
307 dents’ experience of ﬁnancial hardship. Respondents
308 were asked whether, in the past year, had they been
309 seriously behind time in paying each of 14 listed
310 ﬁnancial obligations (e.g. water bill, mortgage repay-
311 ment, child support). Each response was coded as (yes/
312 no: 1/0), and accumulated into a single index reﬂecting
313 the difﬁculty the respondent had with debt in the pre-
314 vious year. Respondents were then asked whether
315 during the previous year they had to borrow money to
316 pay for day-to-day needs from four potential sources
317 (pawnbroker, money lender, bank or friends/family).
318 Responses were coded as (yes/no: 1/0) and accumu-
319 lated into a single variable. For both indices higher
320 scores indicate higher levels of debt or borrowing
321 during the previous year.
322 Trauma
323 Experience of three categories of trauma represented
324 lifetime experience of traumatic events for the partici-
325 pants: SLE, victimization and CSA. Experiences of SLE,
326 such as serious illness, bereavement and being made
327 redundant from work were measured using 11 items
328derived from the List of Threatening Experiences (LTE) as
329indicators (Brugha et al. 1985). For this analysis, each
330LTE itemwas scored to assess having experienced (1) or
331not having experienced (0) the event and aggregated
332into a single index with a range of 0–11. Moreover,
333participants were asked about lifetime experience of
334victimization. Each of seven items (bullying, violence at
335work, violence in the home, sexual abuse, expulsion
336from school, running away from home, homelessness)
337was scored representing the presence/absence (1/0) of
338each type of victimization. These were then summed to
339provide a total victimization score. Higher scores reﬂect
340more types of victimization experienced. Regarding
341CSA, participants were informed that this section of the
342interview could potentially cause emotional upset, and
343that all answers would be conﬁdential. It was also self-
344completed on the computer so the interviewer could
345not see the responses. Respondents were asked whe-
346ther, before the age of 16: (a) anyone had talked to them
347in a sexual way; (b) anyone touched them in a sexual
348way without consent; or (c) engaged them in sexual
349intercourse without consent. These three questions
350were each coded as binary (1=yes, 0=no), and then
351transformed into a single binary variable representing
352experience of any type of CSA (1= any CSA;
3530=no CSA).
354Antidepressant use
355Respondents were asked whether they were currently
356taking any of the following 13 antidepressant medica-
357tions (Prozac, Lustral, Seroxat, Effexor, Nardil,
358Manerix, Tryptizol, Tofranil, Anafranil, Prothiaden,
359Sinequan, Cipramil, Zispen). If yes, they were asked to
360show the interviewer the medication package. Produ-
361cing the wrong medication package resulted in exclu-
362sion from that particular medication. From this a binary
363variable was derived classifying respondents as taking
364no antidepressants (0), or one or more (1).
365Analysis strategy
366A multivariate binary logistic regression model was
367speciﬁed and tested using SPSS 24 to assess the impact
368of predictor variables on the likelihood that respon-
369dents were currently using an antidepressant. It was
370expected that the 14 predictors of antidepressant use
371would produce a statistically signiﬁcant model. For
372each predictor, there was ≤1.5% of missing data due to
373participants identifying items as not applicable,
374answering ‘don’t know’ or refusing to answer. The
375missing data were missing completely at random
376(Little’s MCAR test: χ2= 20.789, df= 14, p= 0.187) and
377handled using listwise deletion. Predictors were inclu-
378ded in the model simultaneously. χ2 Tests were used to
379assess the goodness of model ﬁt.
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380 Results
381 There were 417 (5.6%) participants who reported
382 current use of antidepressants in the cohort and the
383 cross-tabulations with the predictor variables are
384 reported in Table 1.
385 Mean scores on cumulative predictors for those cur-
386 rently taking/not taking antidepressants are presented
387 in Table 2. On ﬁnancial hardship (debt and borrowing)
388 and trauma (SLE and victimization) indicators, mean
389 scores were consistently higher in the current anti-
390 depressant use group. For debt, borrowing and victi-
391 mization, the mean scores of the current antidepressant
392 use group were more than twice those of the no current
393 antidepressant use group.
394 As shown in Table 3, all bivariate associations
395 were statistically signiﬁcant. Larger effects were observed
396 for depression, CSA and English as ﬁrst language. The
397 weakest effects were observed for living alone and having
398 no qualiﬁcations.
399 Table 3 shows the estimates from the multivariate
400 logistic regression model where all predictor variables
401 were entered into the model with current antidepressant
402 use as the dependent variable. The overall model
403was statistically signiﬁcant (χ2(19)= 522.76, p< 0.001)
404and explained between 7% (Cox and Snell’s R2) and
40520% (Nagelkerke’s R2) of the variance in current
Table 1. Counts and percentages for current antidepressant use and
risk factors
Predictor
No current ADM use
(n= 6971)
Current ADM use
(n= 417)
Depression
None 3947 (56.6%) 92 (22.1%)
Either screener 2216 (31.8%) 154 (36.9%)
Both screeners 807 (11.6%) 171 (41.0%)
Age
16–29 1012 (14.5%) 36 (8.6%)
30–44 1837 (26.4%) 127 (30.5%)
45–59 1601 (23.0%) 145 (34.8%)
60+ 2521 (36.2%) 109 (26.1%)
Female 3886 (55.7%) 307 (73.6%)
Living alone 1940 (27.8%) 147 (35.3%)
English as ﬁrst
language
6563 (94.4%) 408 (97.8%)
PHFI
None 5325 (75.1%) 214 (51.3%)
Either indicator 549 (7.9%) 46 (11.1%)
Both indicators 1187 (17.0%) 157 (37.6%)
Unemployed 3310 (47.8%) 273 (65.9%)
Renting home 1961 (28.4%) 181 (43.8%)
No qualiﬁcations 1966 (28.4%) 139 (33.6%)
CSA 861 (12.5%) 121 (29.9%)
ADM, antidepressant medication; PHFI, physical health-
related functional impairment; CSA, childhood sexual abuse.
Pearson‘s χ2 tests for antidepressant use and all risk factors
reached statistical signiﬁcance (p< 0.001).
Table 2. Comparison of means and standard deviations of scores on
cumulative risk factors between those currently taking or not taking
antidepressants
No current ADM use
[mean (S.D.)]
Current ADM use
[mean (S.D.)]
Debt 0.17 (0.77) 0.47 (1.27)
Borrowing 0.09 (0.35) 0.24 (0.60)
SLE 3.11 (1.94) 3.98 (2.07)
Victimization 0.43 (0.83) 1.05 (1.31)
ADM, antidepressant medication; SLE, stressful life events.
Independent samples t-tests for antidepressant use and all
risk factors reached statistical signiﬁcance (p< 0.01).
Table 3. Bivariate and multivariate odds ratios (OR) from binary
logistic regression analyses of current antidepressant use and
risk factors
Current ADM use
Bivariate Multivariate
OR 95% CI OR 95% CI
Depression (ref=none)
Either screener 2.77*** 2.18–3.62 2.13*** 1.61–2.81
Both screeners 6.81*** 5.12–9.10 3.85*** 2.81–5.26
ICD-10 depressive
episode
22.55*** 15.83–32.12 9.04*** 6.01–13.60
Age (ref= 60+)
16–29 0.82 0.56–1.21 0.81 0.49–1.32
30–44 1.60*** 1.23–2.08 1.84** 1.29–2.64
45–59 2.10*** 1.62–2.71 1.97*** 1.43–2.72
Female 2.22*** 1.77–2.77 1.96*** 1.53–2.51
Living alone 1.41** 1.14–1.74 1.06 0.82–1.36
First language is
English
2.82** 1.45–5.50 3.48** 1.51–8.02
PHFI (ref=none)
Either indicator 2.05*** 1.47–2.85 1.52* 1.05–2.18
Both indicators 3.24*** 2.61–4.01 1.57** 1.22–2.04
Unemployed 2.12*** 1.72–2.61 1.82*** 1.40–2.38
Renting home 1.97*** 1.61–2.41 1.22 0.95–1.58
No qualiﬁcations 1.28* 1.03–1.57 1.01 0.78–1.32
Debt 1.30*** 1.21–1.41 1.01 0.90–1.13
Borrowing 2.00*** 1.67–2.39 1.15 0.89–1.48
SLE 1.23*** 1.17–1.28 1.07 1.00–1.13
Victimization 1.68*** 1.55–1.81 1.18** 1.06–1.32
CSA 2.98*** 2.38–3.73 1.53** 1.16–2.00
ADM, antidepressant medication; CI, conﬁdence interval;
PHFI, physical health-related functional impairment; SLE,
stressful life events; CSA, childhood sexual abuse.
*p< 0.05, **p< 0.01, ***p< 0.001.
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406 antidepressant use. Seven of the predictors did not make
407 a statistically signiﬁcant contribution to the model: age
408 16–30, living alone, renting home, no qualiﬁcations,
409 debt, borrowing and SLE. All other variables remained
410 statistically signiﬁcant. Overall, the strongest predictor
411 of current antidepressant use was an ICD-10 depressive
412 episode [OR= 9.04; conﬁdence intervals (CI)= 6.01–
413 13.60], followed by saying yes to both screeners of
414 depression (OR= 3.85; CI= 2.81–5.26) and English as
415 ﬁrst language (OR= 3.48; CI= 1.51–8.02). Use was
416 higher in females than males (OR= 1.96; CI= 1.53–
417 2.51), and risk of use for those who were middle-aged
418 was double that of those aged 60 or more (OR= 1.97;
419 CI= 1.43–2.72). Reporting experience of CSA was
420 associated with an approximate 50% increased risk for
421 antidepressant use.
422 Discussion
423 The current study utilized data from the APMS to
424 assess a range of important personal, socioeconomic
425 disadvantage and trauma-related predictors for current
426 antidepressant use. The results supported the primary
427 hypothesis. The 14 predictors of antidepressant
428 use were all individually signiﬁcantly associated
429 with antidepressant use. With regards to the second
430 hypothesis, several of factors that have been investi-
431 gated previously (depression, middle-age and female
432 gender) individually and signiﬁcantly contributed to
433 antidepressant use in the multivariate model. These
434 results were consistent with previous research ﬁndings
435 (Demyttenaere et al. 2008; Butterworth et al. 2013; Lewer
436 et al. 2015). In this analysis there were increased odds
437 of antidepressant use in the two middle-adulthood
438 groups, andmembership of the youngest age group did
439 not signiﬁcantly increase odds of antidepressant use in
440 comparison to the oldest age group. An explanation for
441 this may be that antidepressant use rises and falls with
442 the lifetime prevalence of depression, which increases
443 into middle adulthood before dropping in older adult-
444 hood (Kessler et al. 2003). Moreover, of the previously
445 investigated socioeconomic disadvantage indicators,
446 only unemployment signiﬁcantly independently con-
447 tributed to the multivariate model. In this analysis
448 unemployment actually performed better than it did
449 in an analysis by Butterworth et al. (2013), as it
450 remained a signiﬁcant predictor of antidepressant use
451 in a model including depression (Butterworth et al.
452 2013). With regards to the other four socioeconomic
453 disadvantaged indicators (renting home, no qualiﬁca-
454 tions, debt and borrowing) the results indicated that
455 they failed to independently contribute to the multi-
456 variate model. These mixed results for indicators of
457 socioeconomic disadvantage as predictors of anti-
458 depressant use add to an already inconclusive evidence
459base (Demyttenaere et al. 2008; Butterworth et al. 2013;
460Lewer et al. 2015) and highlight the need for further
461investigation.
462Furthermore, this study used some variables that
463have not been examined in previous research (living
464alone, migrant status, PHFI, SLE, victimization and
465CSA), and of these migrant status (English as ﬁrst
466language) was the strongest predictor. PHFI, victimi-
467zation and CSA were also signiﬁcant predictors of
468antidepressant use. However, the hypothesis failed to
469be supported for social isolation (measured by living
470alone) and SLE, as they failed to independently and
471signiﬁcantly contribute to the model. This is surprising
472as they are both predictors of general psychopathology
473(Molnar et al. 2001; Joutsenniemi et al. 2006), and as
474living alone has previously predicted antidepressant
475use in a working-age population (Pulkki-Råback
476et al. 2012).
477This analysis indicated that even when depressive
478symptoms are controlled for, those experiencing poor
479social and economic circumstances are more likely to
480be prescribed antidepressant medications. As such, it
481is believed that this analysis adds to the long-term
482documentation of the failure of our services to address
483the social causes of depression and distress.
484The main strengths of this study are that it is based
485on a large, nationally representative sample, and
486that the APMS 2007 survey methods are stringent
487(McManus et al. 2009). In addition, participants in the
488APMS 2007 were required to show medication packa-
489ges when reporting which antidepressants they used,
490arguably a more objective mechanism than recall alone.
491However, there are limitations associated with this
492study. First, this was a study of individual-level pre-
493dictors. It did not take into account broader societal
494factors, such as reductions in the stigma associated with
495mental health and its treatment (Angermeyer et al.
4962017). Next, there can be issues with analyses based on
497individual-level self-report data. Whilst self-report data
498are less problematic for factors such as demographics, it
499may have repercussions for other indicators in this
500study. Evaluating trauma experienced over the lifetime
501is complex, involving issues with validity of reports
502and issues of deﬁnition (Goodman et al. 1998). Yet,
503whilst the reliability and validity of self-reported
504trauma in this study cannot be deﬁnitively estab-
505lished, evidence suggests these accounts are reliable in
506population and clinical samples (Fisher et al. 2011).
507Moreover, this analysis was limited to using ﬁrst lan-
508guage and living alone as proxies for migrant status
509and social isolation respectively. Where possible more
510direct indicators should be utilized, for example UCLA
511Loneliness Scale (Russell et al. 1978).
512Diagnosis of an ICD-10 depressive episode was the
strongest predictor of antidepressant use in this
6 S. Boyle et al.
513 multivariate analysis. This result is in agreement with
514 previous literature, but the OR (9.04) was higher than
515 that recorded in previous work (OR= 5.00: Demytte-
516 naere et al. 2008). This is probably due to differences in
517 the operationalization of depression between studies.
518 This study utilized a combined variable with ICD-10
519 depressive episode measured using the CIS-R. Previous
520 works have utilized 12-month prevalence of depression
521 measured using the Composite International Diag-
522 nostic Interview (Demyttenaere et al. 2008), and 4-week
523 prevalence using theMental Health Inventory-5 (Lewer
524 et al. 2015). Further work is required to ascertain a
525 consensus.
526 Furthermore, it must be taken into consideration
527 that this survey was completed on private households
528 only. Research has shown that there are high, often
529 inappropriate rates of antidepressant prescribing
530 to the elderly in residing in care homes (Read et al.
531 2016). Our ﬁnding that risk of antidepressant use is
532 highest in middle-age must be interpreted with this
533 in mind.
534 In conclusion, using a large nationally representative
535 data set of adults in England, this study provides evi-
536 dence of the relative strength of a range of personal,
537 socioeconomic and trauma-related factors in predicting
538 antidepressant use. This study has conﬁrmed that
539 depression, age, gender, English as ﬁrst language,
540 PHFI, unemployment, victimization and CSA sig-
541 niﬁcantly predict antidepressant use. These ﬁndings
542 have potentially important clinical implications for
543 service planning of psychosocial services. There has
544 been a reduction in stigma regarding mental health
545 treatment, leading to increased numbers seeking
546 treatment and massive pressures on resources, parti-
547 cularly in primary care services (Angermeyer et al.
548 2017). Indeed, GPs in the UK have reported that
549 they are prescribing more antidepressants because of
550 poor access to psychosocial services, including long
551 waiting times (Mental Health Foundation, 2005).
552 Thus, identifying these predictors is the ﬁrst step in
553 identifying those most in need so that psychosocial
554 services can be targeted towards those groups. It is
555 recommended that future work builds upon these
556 ﬁndings via the development of ‘high-risk’ proﬁles
557 and longitudinal modelling of the effects of these
558 predictors on antidepressant use. Further research is
559 warranted so that the broader context of current anti-
560 depressant use in the population can be understood
561 and accounted for.
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